Physician profile
Christopher E Cenac
NPI 1366414732
$33,068.99
in general payments reported to CMS, 2019-2025
45 companies · $8,044 in 2025
The $8,044 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $312 · 2021: $1,038 · 2022: $7,650 · 2023: $2,196 · 2024: $404 · 2025: $8,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,568 · Travel and Lodging: $1,604 · Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,568.00 |
| Travel and Lodging | $1,603.96 |
| Food and Beverage | $1,471.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $12,500.00 | 2019 | |
| Precision Spine, INC. | $11,414.39 | 2021-2025 | |
| Zavation Medical Products, LLC | $3,670.88 | 2024-2025 | |
| Life Spine, INC. | $1,772.25 | 2022-2023 | Centric-S, Cervical Plage, Prolift Pivot |
| Abbott Laboratories | $469.32 | 2024-2025 | Eterna, Proclaim |
| Corelink, LLC | $306.44 | 2019-2021 | |
| Amgen INC. | $248.32 | 2019-2022 | |
| Providence Medical Technology, INC. | $223.62 | 2021-2024 | |
| Alphatec Spine, INC | $189.05 | 2022 | |
| Si-Bone, INC. | $188.15 | 2019-2023 | |
| Medtronic USA, INC. | $168.79 | 2019 | |
| Seaspine Orthopedics Corporation | $140.29 | 2021 | |
| Ferring Pharmaceuticals INC. | $129.67 | 2019-2022 | |
| Nuvasive, INC. | $122.51 | 2020 | |
| Orthofix Medical, INC. | $109.85 | 2023 | Mariner Mis Tlif Retractor, Meridian |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $107.01 | 2021 | |
| Nexxt Spine LLC | $98.64 | 2022-2024 | Connexx Mis System, Struxxure Mcs System |
| Radius Health, INC. | $94.80 | 2019-2023 | |
| Neo Spine USA, INC. | $89.97 | 2021 | |
| Collegium Pharmaceutical, INC. | $82.40 | 2019 | |
| Depuy Synthes Sales INC. | $82.36 | 2020-2021 | |
| Stryker Corporation | $72.31 | 2025 | Aequalis Perform Reversed |
| Arbor Pharmaceuticals, INC. | $70.27 | 2019-2021 | |
| Spineology INC. | $68.84 | 2023 | Optimesh Expandable Interbody Fusion System |
| Pacira Pharmaceuticals Incorporated | $66.61 | 2019-2024 | Exparel, Iovera, Zilretta |
| Medtronic, INC. | $48.68 | 2021-2024 | Invos |
| Allergan, INC. | $44.74 | 2019 | |
| Lifenet Health | $43.90 | 2022 | |
| Forte Bio-Pharma LLC | $42.59 | 2019-2021 | |
| Horizon Therapeutics Plc | $41.76 | 2019 | |
| Integrity Implants INC. Dba Accelus | $39.88 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $39.27 | 2022-2023 | Seglentis |
| Cerapedics INC. | $38.98 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Azurity Pharmaceuticals, INC. | $31.36 | 2023 | Horizant |
| Smith+Nephew, INC. | $28.28 | 2020 | |
| Pacira Therapeutics, INC. | $23.73 | 2019 | |
| Ctl Medical Corporation | $23.47 | 2021 | |
| Spinal Simplicity, LLC | $22.83 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.46 | 2019 | |
| Bioventus LLC | $17.80 | 2024 | Durolane |
| Ermi LLC | $17.46 | 2021 | |
| Tactile Systems Technology INC | $15.88 | 2021 | |
| Abbvie INC. | $14.57 | 2022 | |
| Theragen, INC. | $13.01 | 2023 | Actastim-S |
| Pfizer INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cenac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.